Table 3 |
||||||
|
Hemodynamic parameters in patients with and without sepsis |
||||||
|
Patients with sepsis |
Patients without sepsis |
|||||
|
|
|
|||||
|
Hemodynamic variable* |
DEX (n = 31) |
LZ (n = 31) |
P value |
DEX (n = 20) |
LZ (n = 19) |
P value |
|
|
||||||
|
Number of days on vasoactive drugs |
1 (1) |
2 (2) |
0.08 |
1.5 (2.2) |
0.3 (0.9) |
0.08 |
|
Average daily number of vasoactive drugs |
1.1 (0.2) |
1.6 (0.5) |
0.004 |
1.6 (0.9) |
1 (0) |
0.2 |
|
Ever vasoactive drugs increased |
26% |
47% |
0.08 |
33% |
16% |
0.2 |
|
Sinus bradycardia (<60 beats/min) |
13% |
6% |
0.4 |
24% |
0% |
0.02 |
|
Sinus tachycardia (>100 beats/min) |
81% |
84% |
0.7 |
52% |
53% |
1 |
|
|
||||||
|
Mean (standard deviation) unless otherwise noted. DEX, dexmedetomidine; LZ, lorazepam. *Measured during 120-hour study drug protocol, except for sinus bradycardia and sinus tachycardia, which are measured during entire study. |
||||||
|
Pandharipande et al. Critical Care 2010 14:R38 doi:10.1186/cc8916 |
||||||